Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment

Mostrar otras versiones (1)

Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Despite initial responsiveness, 80% of EOC patients recur and present with chemoresistant and a more aggressive disease. This suggests an underlying biology that results in a modified recurrent disease, which is distinct from...

Descripción completa

Detalles Bibliográficos
Autores principales: Craveiro, Vinicius, Yang-Hartwich, Yang, Holmberg, Jennie C, Sumi, Natalia J, Pizzonia, John, Griffin, Brian, Gill, Sabrina K, Silasi, Dan-Arin, Azodi, Masoud, Rutherford, Thomas, Alvero, Ayesha B, Mor, Gil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892380/
https://www.ncbi.nlm.nih.gov/pubmed/24403249
http://dx.doi.org/10.1002/cam4.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892380/
https://www.ncbi.nlm.nih.gov/pubmed/24403249
http://dx.doi.org/10.1002/cam4.115

Ejemplares similares